Research Article
General and Electrophysiological Toxic Effects of Manganese in Rats following Subacute Administration in Dissolved and Nanoparticle Form
Table 1
Treatment scheme with group codes, doses and treatment times.
| Group code | Treatment and dose |
| C3 | 3 weeks, untreated | VC3 | 3 weeks, distilled water, orally | MnL3 | 3 weeks 14.84 mg/kg b.w. MnCl2, orally | MnH3 | 3 weeks 59.36 mg/kg b.w. MnCl2, orally | C33 | 6 weeks, untreated* | VC33 | 3 weeks, distilled water, orally + 3 weeks HEC intratracheally | MnL33 | 3 weeks 14.48 mg/b.w. kg MnCL2, orally + 3 weeks MnO2 NPs 2.63 mg/kg b.w. intratracheally | MnH33 | 3 weeks 59.36 mg/b.w. kg MnCL2, orally + 3 weeks MnO2 NPs 2.63 mg/kg b.w. intratracheally | C6 | 6 weeks, untreated* | VC6 | 6 weeks, distilled water, orally | MnL6 | 6 weeks 14.84 mg/kg b.w. MnCl2, orally | MnH6 | 6 weeks 59.36 mg/kg b.w. MnCl2, orally |
|
|
*C33 and C6 were two different groups of rats.
|